Larry Corey, MD, is a Professor in the Vaccine and Infectious Disease Division and the former President and Director of the Fred Hutchinson Cancer Research Center, USA. He is also a Professor in Medicine and Laboratory Medicine & Pathology at the University of Washington. Larry’s scientific focus is on medical virology and vaccine development. His research focuses on herpes viruses, HIV, COVID-19 and other viral infections, including those associated with cancer.
He is the founder and principal investigator of the HIV Vaccine Trials Network (HVTN), which conducts studies of HIV vaccines at over 80 clinical trials sites in 16 countries on five continents. Under his leadership, the HVTN has become the model for global, collaborative research. Larry is also the principal investigator of the Fred Hutch-based operations centre of the COVID-19 Prevention Network and co-leads the network’s COVID-19 vaccine testing pipeline, which designed and coordinated the large US government portfolio of COVID-19 vaccines and monoclonal antibody trials.
Larry is a member of the US National Academy of Medicine and the American Academy of Arts and Sciences. He has received the Parran Award for his work in HSV-2, the American Society of Microbiology Cubist Award for his work on antivirals, and the University of Michigan Medical School Distinguished Alumnus Award. He is one of the most highly cited biomedical researchers in the past 20 years and is the author, co-author or editor of over 1,000 scientific publications.